Psylocybin – breakthrough in serotonin reuptake to relieve depression

Psilocybin for major depression granted Breakthrough Therapy by FDA The FDA has awarded another Breakthrough Therapy designation for psilocybin, this time focusing on research into the effect of a single dose on patients suffering from major depressive disorder. The US Food and Drug Administration (FDA) has granted psilocybin therapy a Breakthrough Therapy designation for the …

Psylocybin – breakthrough in serotonin reuptake to relieve depression Read More »